{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:21:05Z","timestamp":1789348865390,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sapharm.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:12:51Z","timestamp":1744146771000},"page":"687-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact evaluation of the modified adverse inpatient medication event (AIME-Frail) model in hospitalised adults"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-0776","authenticated-orcid":false,"given":"Jonathan Yong Jie","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abdel-Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Centaine","family":"Snoswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sapharm.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7861\/clinmedicine.16-5-481","article-title":"Adverse drug reactions","volume":"16","author":"Coleman","year":"2016","journal-title":"Clin Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40545-023-00579-4","article-title":"Experience and attitudes of pharmacists towards challenges and adaptive measures to new norm in ward pharmacy practice during the COVID-19 pandemic","volume":"16","author":"Ng","year":"2023","journal-title":"J Pharm Policy and Practice"},{"issue":"Sp","key":"10.1016\/j.sapharm.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.12927\/hcq.2009.20719","article-title":"Implementation of admission medication reconciliation at two academic health sciences centres: challenges and success factors","volume":"12","author":"Coffey","year":"2009","journal-title":"Healthc Q"},{"issue":"3","key":"10.1016\/j.sapharm.2025.04.002_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.sapharm.2019.05.011","article-title":"Implementing a sustainable medication reconciliation process in Australian hospitals: the World Health Organization High 5s project","volume":"16","author":"Stark","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"e1","key":"10.1016\/j.sapharm.2025.04.002_bib5","article-title":"Patient prioritisation for hospital pharmacy services: current approaches in the UK","volume":"28","author":"Aseel","year":"2021","journal-title":"Eur J Hosp Pharm"},{"issue":"S2","key":"10.1016\/j.sapharm.2025.04.002_bib6","first-page":"S32","article-title":"Chapter 9: staffing levels and structure for the provision of clinical pharmacy services","volume":"43","year":"2013","journal-title":"J Pharm Pract Res"},{"issue":"6","key":"10.1016\/j.sapharm.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/ejhpharm-2017-001395","article-title":"Right patient, right time, right pharmacist: the time for clinical prioritisation tools?","volume":"24","author":"Lewis","year":"2017","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.sapharm.2025.04.002_bib8","series-title":"Prioritizing Patients for Medication Review by Acute Ward Pharmacists\u2013A Mixed Methods Study in a Danish Hospital","author":"Almarsd\u00f3ttir","year":"2022"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11096-022-01515-3","article-title":"Prioritizing patients for medication review by emergency department pharmacists: a multi-method study","volume":"45","author":"Almarsd\u00f3ttir","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2025.04.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2021.02.009","article-title":"Development of the adult complexity tool for pharmaceutical care (ACTPC) in hospital: a modified Delphi study","author":"Alshakrah","year":"2021","journal-title":"Res Soc Adm Pharm : RSAP"},{"issue":"4","key":"10.1016\/j.sapharm.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2146\/ajhp130247","article-title":"Development of an electronic patient prioritization tool for clinical pharmacist interventions","volume":"71","author":"Falconer","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2025.04.002_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/bcp.14560","article-title":"Development and validation of the adverse inpatient medication event model (AIME)","volume":"87","author":"Falconer","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.sapharm.2025.04.002_bib13","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.sapharm.2021.08.014","article-title":"Developing PHarmacie-R: a bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission","volume":"18","author":"Criddle","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1186\/s12913-021-07033-8","article-title":"Associations of person-related, environment-related and communication-related factors on medication errors in public and private hospitals: a retrospective clinical audit","volume":"21","author":"Manias","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1060028015621071","article-title":"Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study","volume":"50","author":"Wimmer","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine safety: when many is not too many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.sapharm.2025.04.002_bib17","series-title":"A Guide to Medication Reviews for NSW Health Services","year":"2019"},{"issue":"3","key":"10.1016\/j.sapharm.2025.04.002_bib18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/bcp.14560","article-title":"Development and validation of the adverse inpatient medication event model (AIME)","volume":"87","author":"Falconer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.sapharm.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.pec.2020.05.013","article-title":"The association between frailty and medication adherence among community-dwelling older adults with chronic diseases: medication beliefs acting as mediators","volume":"103","author":"Qiao","year":"2020","journal-title":"Patient Educ Counsel"},{"issue":"5","key":"10.1016\/j.sapharm.2025.04.002_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","article-title":"Scoping review of studies evaluating frailty and its association with medication harm","volume":"39","author":"Lam","year":"2022","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.sapharm.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.sapharm.2024.05.003","article-title":"The adverse inpatient medication event and frailty (AIME-frail) risk prediction model","volume":"20","author":"Falconer","year":"2024","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2025.04.002_bib22","article-title":"Evaluating the impact and use of transparent reporting of Evaluations with non-randomised designs (TREND) reporting guidelines","volume":"2","author":"Thomas","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.04.002_bib27","series-title":"Australian Medicines Handbook","author":"Health Communication","year":"1998"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00228-018-2567-5","article-title":"Defining and classifying terminology for medication harm: a call for consensus","volume":"75","author":"Falconer","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.sapharm.2025.04.002_bib24","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/bcp.13716","article-title":"Development of a standardized chart review method to identify drug-related hospital admissions in older people","volume":"84","author":"Thevelin","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2025.04.002_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: detection and classification methods","volume":"13","author":"Morimoto","year":"2004","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.sapharm.2025.04.002_bib26","unstructured":"World Health Organization-Uppsala Monitoring Centre (WHO-UMC) The use of the WHO-UMC system for standardised case causality assessment [Available from:: https:\/\/who-umc.org\/media\/164200\/who-umc-causality-assessment_new-logo.pdf."},{"issue":"6","key":"10.1016\/j.sapharm.2025.04.002_bib28","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2025.04.002_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jppr.1255","article-title":"The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay","volume":"47","author":"Paradissis","year":"2017","journal-title":"J Pharm Pract Res"},{"issue":"8","key":"10.1016\/j.sapharm.2025.04.002_bib31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00228-012-1237-2","article-title":"A prospective analysis of the preventability of adverse drug reactions reported in Sweden","volume":"68","author":"L\u00f6vborg","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmjqs-2019-009587","article-title":"Medication-related harm in older adults following hospital discharge: development and validation of a prediction tool","volume":"29","author":"Nikesh","year":"2020","journal-title":"BMJ Quality \\&; Safety"},{"issue":"10","key":"10.1016\/j.sapharm.2025.04.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111254","article-title":"Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: brighton Adverse Drug Reactions Risk (BADRI) model","volume":"9","author":"Tangiisuran","year":"2014","journal-title":"PLoS One."},{"issue":"17","key":"10.1016\/j.sapharm.2025.04.002_bib34","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/archinte.163.17.2014","article-title":"Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units","volume":"163","author":"Kucukarslan","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.sapharm.2025.04.002_bib35","series-title":"Hospital Mortality Data. Brisbane, Australia: Princess Alexandra Hospital","article-title":"Princess Alexandra hospital information management services","year":"2022"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12877-022-03003-9","article-title":"Predictors of hospital-acquired adverse drug reactions: a cohort of Ugandan older adults","volume":"22","author":"Yadesa","year":"2022","journal-title":"BMC Geriatrics"},{"key":"10.1016\/j.sapharm.2025.04.002_bib37","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"10.1016\/j.sapharm.2025.04.002_bib38","unstructured":"RT. Rstudio: integrated development for R. RStudio, PBC, Boston2020."},{"key":"10.1016\/j.sapharm.2025.04.002_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jppr.1929","article-title":"Prospective identification of medication harm in geriatric inpatients using a modified trigger tool","author":"Wang","year":"2024","journal-title":"Journal of Pharmacy Practice and Research"},{"issue":"5","key":"10.1016\/j.sapharm.2025.04.002_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jppr.1255","article-title":"The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay","volume":"47","author":"Paradissis","year":"2017","journal-title":"Journal of Pharmacy Practice and Research"},{"issue":"4","key":"10.1016\/j.sapharm.2025.04.002_bib41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1071\/AH13166","article-title":"Exploring in-hospital adverse drug events using ICD-10 codes","volume":"38","author":"Parikh","year":"2014","journal-title":"Aust Health Rev"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11096-017-0583-7","article-title":"Antihypertensive-related adverse drug reactions among older hospitalized adults","volume":"40","author":"Alhawassi","year":"2018","journal-title":"International Journal of Clinical Pharmacy"},{"key":"10.1016\/j.sapharm.2025.04.002_bib43","series-title":"Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: a systematic review and meta-analysis","volume":"9","author":"Yadesa","year":"2021"},{"issue":"15","key":"10.1016\/j.sapharm.2025.04.002_bib44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jama.280.15.1311","article-title":"Effect of computerized physician order entry and a team intervention on prevention of serious medication errors","volume":"280","author":"Bates","year":"1998","journal-title":"Jama"},{"key":"10.1016\/j.sapharm.2025.04.002_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2023.100335","article-title":"Enhancing the clinical pharmacy service of a large teaching hospital: development of a new clinical prioritisation tool","volume":"12","author":"Clarke","year":"2023","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00412-2021","article-title":"Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism","volume":"59","author":"Jim\u00e9nez","year":"2022","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s43058-022-00326-x","article-title":"Barriers and enablers to implementing and using clinical decision support systems for chronic diseases: a qualitative systematic review and meta-aggregation","volume":"3","author":"Chen","year":"2022","journal-title":"Implementation Science Communications"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cpr.2010.09.007","article-title":"Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation","volume":"31","author":"Gearing","year":"2011","journal-title":"Clinical Psychology Review"},{"issue":"1","key":"10.1016\/j.sapharm.2025.04.002_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169463","article-title":"The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2025.04.002_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.17827\/aktd.1112770","article-title":"Adverse drug reactions with antidepressants drugs: significance of pharmacovigilance in depression pharmacotherapy","volume":"31","author":"Khan","year":"2022","journal-title":"Ar\u015fiv Kaynak Tarama Dergisi"},{"key":"10.1016\/j.sapharm.2025.04.002_bib51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12887-016-0619-5","article-title":"Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia","volume":"16","author":"Dedefo","year":"2016","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.sapharm.2025.04.002_bib52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A systematic review of hospitalization resulting from medicine-related problems in adult patients","volume":"78","author":"Al Hamid","year":"2014","journal-title":"British Journal of Clinical Pharmacology"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:03:48Z","timestamp":1750179828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1551741125002128"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.04.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact evaluation of the modified adverse inpatient medication event (AIME-Frail) model in hospitalised adults","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}